País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
Lamotrigine
Aspen Pharma Pty Ltd
Medicine Registered
SEAZE (lamotrigine) – CMI Page 1 of 4 SEAZE lamotrigine CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you take SEAZE tablets. This leaflet answers some common questions about SEAZE. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the expected benefits of you taking SEAZE tablets against the risks this medicine could have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT SEAZE IS USED FOR Lamotrigine (the active ingredient in SEAZE tablets) belongs to a group of medicines called “anti-epileptic drugs”. SEAZE tablets are used to treat epilepsy in adults and children. Usually SEAZE tablets are initially used in addition to other medicines for the treatment of epilepsy. SEAZE is used in partial or generalised seizures including Lennox-Gastaut Syndrome. An epileptic seizure, fit or turn results when abnormal electrical impulses occur in nerve cells in the brain. These abnormal electrical impulses are believed to be due to altered levels of some chemicals in the brain. It is thought to work by changing the levels of some of the chemicals associated with seizures. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY SEAZE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. SEAZE is available only with a doctor's prescription. There is no evidence that it is addictive. BEFORE YOU T Leer el documento completo
SEAZE (lamotrigine) – Product Information Page 1 of 20 PRODUCT INFORMATION Seaze Severe, potentially life-threatening rashes have been reported in association with the use of lamotrigine, particularly in children. Accordingly, lamotrigine should be discontinued at the first sign of rash unless the rash is clearly not drug related. (See DOSAGE AND ADMINISTRATION). NAME OF THE MEDICINE Lamotrigine. The chemical name for lamotrigine is 3,5-diamino-6- (2,3-dichlorophenyl)- 1,2,4- triazine. Its structural formula is: C 9 H 7 Cl 2 N 5 Molecular weight: 256.09 CAS No.: 84057-84-1 DESCRIPTION Lamotrigine is a substituted asymmetric triazine. It is a white to off-white crystalline powder and is slightly soluble in ethanol and chloroform and very slightly soluble in water. Seaze tablets are dispersible and come in six strengths and contain 2 mg, 5 mg, 25 mg, 50 mg, 100 mg or 200 mg of lamotrigine. The tablets also contain the following excipients: mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, povidone, saccharin sodium, purified talc, magnesium stearate and blackcurrant flavour (ARTG No. 10975). The tablets are gluten free. PHARMACOLOGY The precise mechanism of the anticonvulsant action of lamotrigine is not certain. The results of neurochemical and electrophysiological studies with various in vitro and in vivo preparations indicate that lamotrigine can inhibit voltage gated sodium channels and reduce the release of glutamate, an excitatory amino acid implicated in the pathophysiology of epilepsy. It is possible that these effects underlie inhibition of the sustained Leer el documento completo